Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,743 recruiting studies in this area right now.
By phase
- Not applicable9,868
- Phase 24,491
- Phase 12,735
- Phase 1/Phase 21,687
- Phase 31,413
- Phase 2/Phase 3284
- Phase 4265
Top conditions
- Breast Cancer1,244
- Prostate Cancer661
- Cancer657
- Colorectal Cancer499
- Lung Cancer431
- Ovarian Cancer342
- Multiple Myeloma331
- Gastric Cancer302
- Pancreatic Cancer295
- Acute Myeloid Leukemia290
- Hepatocellular Carcinoma286
- Solid Tumor254
- Advanced Solid Tumor251
- Cervical Cancer233
- Head and Neck Cancer229
- Endometrial Cancer208
- Esophageal Cancer197
- Advanced Solid Tumors196
Leading sponsors
- M.D. Anderson Cancer Center452
- Fudan University321
- National Cancer Institute (NCI)292
- Sun Yat-sen University290
- Memorial Sloan Kettering Cancer Center289
- Mayo Clinic237
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences151
- City of Hope Medical Center147
- AstraZeneca131
- University Health Network, Toronto125
Where studies are running
- California1,433
- Texas644
- Arizona513
- Florida434
- Alabama418
- New York410
- Massachusetts341
- Maryland330
- New Jersey266
- Pennsylvania238
Recruiting studies20,743 total
- NCT06944444RecruitingPhase 1
Testing a new drug for advanced tumors
This trial tests a new drug, SSS59, in people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and how it affects the body.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06944457RecruitingPhase 1
Safety Study of MPD-1 for Advanced Solid Tumors
This trial tests a new drug called MPD-1 for people with advanced solid tumors that have not responded to standard treatments. It focuses on patients with specific genetic changes (KRAS mutation or PTEN loss) to see if the drug is safe and how the body processes it.
SeoulAges 19–75 - NCT06944483Recruiting
Same-Day Radiation Treatment for Large Liver Cancer
This trial tests giving a same-day radiation treatment (radioembolization) for large liver cancers (5 cm or bigger). It might be an option if your liver is still working well and you are in good general health.
GoyangAges 19 years+ - NCT06945042Recruiting
Financial help for adults with new AML starting chemo
This study is testing whether a financial navigation program can help adults with newly diagnosed acute myeloid leukemia (AML) who are about to start or have just started intensive chemo. The goal is to see if providing money guidance reduces stress and improves their care.
Charlotte, North CarolinaAges 18–64 - NCT06945315RecruitingPhase 3
Nerve-Sparing Surgery Guided by Micro-Ultrasound
This study tests whether using a special ultrasound tool during prostate cancer surgery helps protect the nerves that control erections. If you have good erectile function and are scheduled for nerve-sparing prostate removal, this trial may be a good fit for you.
New York, New YorkAges 18 years+ - NCT06945484Recruiting
Exercise program for lung cancer before surgery
This trial tests whether a personalized exercise plan can help people with lung cancer who are getting chemotherapy or immunotherapy before surgery. You’ll be asked to follow an exercise routine during your treatment.
Galveston, TexasAges 18 years+ - NCT06945757Recruiting
Physical activity rehab program for adult cancer patients
This program tests a rehabilitation plan that includes physical activity for people with cancer. It is designed to help you stay active during or after treatment.
Lucerne, Canton of LucerneAges 18–80 - NCT06945718Recruiting
Green dye test for gastric cancer surgery
This trial tests whether a green dye called indocyanine green can help surgeons find and remove more lymph nodes during laparoscopic surgery for advanced stomach cancer. It may improve the chances of removing all cancer.
Fuzhou, FujianAges 18–75 - NCT06945887Recruiting
Arterial embolization for desmoid tumors
This trial tests a treatment called arterial embolization for desmoid tumors (non-cancerous growths) that are causing symptoms and growing. The goal is to see if blocking the blood supply to the tumor can shrink it or stop it from growing.
Bologna, BOAges 12 years+ - NCT06945978Recruiting
Testing a blood test to predict treatment response in advanced pancreatic cancer
This study looks at a special blood test (miRNA panel) to see if it can help predict how well treatment works for people with advanced pancreatic cancer. If you are starting FOLFIRINOX for the first time, you may be able to join.
São Paulo, São PauloAges 18 years+ - NCT06946017Recruiting
Dairy protein and fiber supplement for gut health
This trial tests if a fermented dairy protein drink with added fiber can improve gut symptoms. It is for active people living in Phoenix who may have mild lactose issues.
Phoenix, ArizonaAges 18–50 - NCT06946238Recruiting
Single-dose radiation after surgery for low-risk breast cancer
This trial tests giving a single, very targeted dose of radiation right after surgery for early-stage breast cancer. It is for women age 40+ with small, low-risk tumors (Luminal A or B) that have been fully removed and have not spread to lymph nodes.
MilanAges 40 years+ - NCT06946225RecruitingPhase 1
Combination cell therapy for advanced melanoma or sarcoma
This trial tests a combination of two medicines: one that trains your immune cells to find cancer (ACTengine IMA203) and another that helps the body recognize the tumor (mRNA-4203). It's for people with advanced melanoma or synovial sarcoma who have already tried other treatments.
San Francisco, CaliforniaAges 18 years+ - NCT06946498Recruiting
Local anesthesia thoracoscopy for diagnosing unknown fluid around the lung
This study tests a newer, less invasive procedure to diagnose the cause of fluid buildup around the lung. It uses local anesthesia and a small camera to look inside the chest, which may make diagnosis faster and more comfortable.
Athens, AtticaAges 18–90 - NCT06946615RecruitingPhase 1
Claudin18.2 cell therapy for advanced colorectal cancer
This study tests a new treatment using your own immune cells (called CAR-T and CAR-DC) that are engineered to attack cancer cells with a specific protein (Claudin18.2). It is for people with advanced colorectal cancer who have exhausted standard treatments.
Hangzhou, ZhejiangAges 18–70 - NCT06946771Recruiting
MRI and prostate lesions: understanding diagnosis and prognosis
This trial uses MRI scans to study prostate lesions and see how they relate to diagnosis, pathology, and long-term outcomes. It may help patients with concerns about prostate health get more detailed imaging.
Wuhan, HubeiAges 18 years+ - NCT06946927RecruitingPhase 1
Study of JMKX001899 with other drugs for advanced KRAS G12C lung cancer
This trial tests a new targeted therapy, JMKX001899, combined with other treatments for advanced non-small cell lung cancer that has a specific KRAS G12C mutation. It aims to see if this combination can help shrink tumors or slow cancer growth.
Guangzhou, GuangdongAges 18–75 - NCT06947044Recruiting
Blood markers for bleeding in leukemia patients
This study looks at markers in the blood to understand why low red blood cell counts (anemia) can cause bleeding problems in people with certain leukemias. It may help find better ways to treat or prevent bleeding during early chemotherapy.
Hamilton, OntarioAges 18 years+ - NCT06947083RecruitingPhase 2
Elranatamab after cilta-cel for high-risk multiple myeloma
This trial tests a new drug, elranatamab, for people with multiple myeloma who recently received a CAR-T cell therapy (cilta-cel) but still have high-risk features. The goal is to see if elranatamab can help keep the cancer from coming back.
Tampa, FloridaAges 18 years+ - NCT06947330RecruitingPhase 3
Pain relief after mastectomy: comparing two nerve blocks
This trial compares two types of nerve blocks to see which provides better pain relief after breast removal surgery. Both are injections near chest muscles that can help reduce pain and the need for strong painkillers.
Cairo, WailiAges 21–65 - NCT06947668Recruiting
Biomarker study for people who can't take cisplatin chemo
This study looks at immune system markers in patients with head and neck cancer who cannot receive the standard chemotherapy drug cisplatin. The goal is to understand how well a different chemotherapy drug (docetaxel) combined with radiation works in these patients.
Erlangen, BavariaAges 18 years+ - NCT06947928RecruitingPhase 2/Phase 3
Vaccine plus immunotherapy for Merkel cell cancer
This trial tests an experimental vaccine (IFx-Hu2.0) followed by the immunotherapy drug pembrolizumab in people with advanced Merkel cell carcinoma who have not been treated with checkpoint inhibitors before. The goal is to see if this combination helps shrink or control the cancer.
Los Angeles, CaliforniaAges 18 years+ - NCT06947967RecruitingPhase 3
Tucidinostat plus CHOP for newly diagnosed PTCL-TFH lymphoma
This trial tests a new drug (tucidinostat) added to standard chemotherapy (CHOP) for people newly diagnosed with a specific type of lymphoma called PTCL-TFH. It aims to see if the combination works better than standard treatment alone.
Guangzhou, GuangdongAges 18–80 - NCT06948786RecruitingPhase 2
Pirtobrutinib and Mosunetuzumab for relapsed follicular lymphoma
This trial tests two new drugs, pirtobrutinib and mosunetuzumab, for people with follicular lymphoma that has come back or not responded to earlier treatments. The goal is to see if this combination can help control the cancer.
Seattle, WashingtonAges 18 years+
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,743 recruiting oncology studies from the U.S. registry right now, out of 32,463 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.